These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12122191)

  • 1. Topiramate induced manic episode.
    Jochum T; Bär KJ; Sauer H
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):208-9. PubMed ID: 12122191
    [No Abstract]   [Full Text] [Related]  

  • 2. First break of mania associated with topiramate treatment.
    Schlatter FJ; Soutullo CA; Cervera-Enguix S
    J Clin Psychopharmacol; 2001 Aug; 21(4):464-6. PubMed ID: 11476138
    [No Abstract]   [Full Text] [Related]  

  • 3. Erectile dysfunction with topiramate.
    Holtkamp M; Weissinger F; Meierkord H
    Epilepsia; 2005 Jan; 46(1):166-7. PubMed ID: 15660786
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptoms of parietal epilepsy probably associated to the use of topiramate in a case of temporal epilepsy].
    Hernán-Pérez Torralba L; Amo C; Alonso-Fernández J; Basurte-Villamor MP
    Rev Neurol; 2005 Nov 1-15; 41(9):574-5. PubMed ID: 16254866
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal Wada and neuropsychological testing results due to topiramate therapy.
    McCabe PH; Eslinger PJ
    Epilepsia; 2000 Jul; 41(7):906-8. PubMed ID: 10897166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasogenic erectile dysfunction Topiramate-induced.
    Civardi C; Collini A; Gontero P; Monaco F
    Clin Neurol Neurosurg; 2012 Jan; 114(1):70-1. PubMed ID: 21868149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panic attacks associated with topiramate.
    Damsa C; Warczyk S; Cailhol L; Kelley-Puskas AM; Cicotti A; Lazignac C; Andreoli A
    J Clin Psychiatry; 2006 Feb; 67(2):326-7. PubMed ID: 16566634
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy.
    Mula M; Trimble MR; Sander JW
    Epilepsia; 2003 Dec; 44(12):1573-7. PubMed ID: 14636330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topiramate on cognition.
    Meador KJ
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):134-5. PubMed ID: 11439970
    [No Abstract]   [Full Text] [Related]  

  • 11. Topiramate-induced depression.
    Klufas A; Thompson D
    Am J Psychiatry; 2001 Oct; 158(10):1736. PubMed ID: 11579016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of topiramate in mood stabilization.
    Maidment ID
    Ann Pharmacother; 2002; 36(7-8):1277-81. PubMed ID: 12086564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate can cause lithium toxicity.
    Abraham G; Owen J
    J Clin Psychopharmacol; 2004 Oct; 24(5):565-7. PubMed ID: 15349023
    [No Abstract]   [Full Text] [Related]  

  • 15. Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.
    Harvey AS
    J Paediatr Child Health; 2003 Aug; 39(6):414-5. PubMed ID: 12919492
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study.
    Lykouras L; Hatzimanolis J
    Curr Med Res Opin; 2004 Jun; 20(6):843-7. PubMed ID: 15200741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subsequent manic onset caused by association of vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1993; 19(4):351-2. PubMed ID: 8275923
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive changes during topiramate therapy.
    Davanzo P; Cantwell E; Kleiner J; Baltaxe C; Najera B; Crecelius G; McCracken J
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):262-3. PubMed ID: 11288765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
    Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label adjunctive topiramate in the treatment of bipolar disorders.
    McElroy SL; Suppes T; Keck PE; Frye MA; Denicoff KD; Altshuler LL; Brown ES; Nolen WA; Kupka RW; Rochussen J; Leverich GS; Post RM
    Biol Psychiatry; 2000 Jun; 47(12):1025-33. PubMed ID: 10862801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.